Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932

Watchlist Manager
Wuhan Easy Diagnosis Biomedicine Co Ltd Logo
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Watchlist
Price: 18.76 CNY 0.32% Market Closed
Market Cap: 4.4B CNY
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Wuhan Easy Diagnosis Biomedicine Co Ltd

There are no price targets for Wuhan Easy Diagnosis Biomedicine Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Wuhan Easy Diagnosis Biomedicine Co Ltd Competitors:
Price Targets
W
336570
Won Tech Co Ltd
41% Upside
AORT
Artivion Inc
19% Upside
C
CVRX
CVRx Inc
45% Upside
M
305090
Micro Digital Co Ltd
65% Upside
W
336570
Won Tech Co Ltd
41% Upside
AORT
Artivion Inc
19% Upside
C
CVRX
CVRx Inc
45% Upside
M
305090
Micro Digital Co Ltd
65% Upside
CREO
Creo Medical Group PLC
271% Upside
S
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
22% Upside
DRIO
DarioHealth Corp
53% Upside
P
PRCT
Procept Biorobotics Corp
64% Upside

Revenue
Forecast

Revenue Estimate
Wuhan Easy Diagnosis Biomedicine Co Ltd

For the last 12 years the compound annual growth rate for Wuhan Easy Diagnosis Biomedicine Co Ltd's revenue is 38%.

38%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Wuhan Easy Diagnosis Biomedicine Co Ltd

Operating Income forecast
is not available for
Wuhan Easy Diagnosis Biomedicine Co Ltd

Net Income
Forecast

Net Income Estimate
Wuhan Easy Diagnosis Biomedicine Co Ltd

For the last 12 years the compound annual growth rate for Wuhan Easy Diagnosis Biomedicine Co Ltd's net income is 39%.

39%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Wuhan Easy Diagnosis Biomedicine Co Ltd's stock price target?
Not Available

Wuhan Easy Diagnosis Biomedicine Co Ltd doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 308,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.